Philadelphia, Pennsylvania – Plexus Ventures, a prominent corporate and business development boutique for healthcare companies, is pleased to announce two promotions among its team members.
Gabriele Tundo, Vice President, has been promoted to Partner.
Gabriele joined Plexus in October 2015 and has contributed to the firm’s M&A, asset divestment and licensing projects. He has also implemented successful business development campaigns in various countries and segments of the healthcare industry, such as diagnostics and medical devices. During the last year, Gabriele led the development of Plexus’ capabilities in the field of Digital Therapeutics, resulting in the creation of a partnership with the Healthware Group.
Daniel Sieiro, Scientific Associate, has been promoted to Manager, Innovation.
Daniel joined Plexus in 2019 from Harvard Medical School and has led Plexus efforts in cutting-edge fields of healthcare such as cell and gene therapy. Daniel’s management of relationships with companies operating in these fields has resulted in several important, new projects for Plexus Ventures. His scientific expertise has enabled him to both evaluate and contribute to projects with an innovative approach.
Bob Moran, Plexus President, noted: “Gabriele Tundo and Daniel Sieiro are young, highly motivated executives dedicated to establishing future business directions for our firm. They have spearheaded efforts to build awareness of Plexus Ventures in digital therapeutics and in gene and cell therapy. These are exciting new areas for Plexus which complement our well-regarded capabilities in pharmaceuticals and consumer healthcare.”
